Artikel ; Online: Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation - Results of the J-RHYTHM Registry 2.
Circulation journal : official journal of the Japanese Circulation Society
2016 Band 80, Heft 4, Seite(n) 843–851
Abstract: ... effects of non-vitamin K antagonist oral anticoagulants (NOACs) in Japanese patients ...
Abstract | Background: The J-RHYTHM Registry 2 was a multicenter, prospective observational study that extended the follow-up period of the J-RHYTHM Registry in order to investigate long-term outcomes and effects of non-vitamin K antagonist oral anticoagulants (NOACs) in Japanese patients with atrial fibrillation (AF). Methods and results: Among 6,616 patients with nonvalvular AF (NVAF) (men 71.0%, 69.7±9.9 years, CHADS2score 1.7±1.2), event rates were compared among patients receiving warfarin (n=3,964), NOACs (n=923), and no anticoagulation therapy (No-OAC, n=753) at the end of follow-up, except for 976 patients lacking anticoagulant data. During the 5-year follow-up period, thromboembolism occurred in 196 (4.9%), 19 (2.1%), and 45 (6.0%) patients, respectively; major hemorrhage in 233 (5.9%), 22 (2.4%), and 36 (4.8%); all-cause death in 230 (5.8%), 13 (1.4%), and 105 (13.9%), (P<0.001 for each). After adjusting for the components of the CHA2DS2-VASc score and antiplatelet drug use, the odds ratio (OR) in the Warfarin group was significantly lower for all-cause death compared with that in the No-OAC group (OR 0.30, 95% confidence interval [CI] 0.23-0.39, P<0.001), whereas ORs in the NOACs group were significantly lower for all events (OR 0.42, 95% CI 0.24-0.74, P=0.003 for thromboembolism; OR 0.53, 95% CI 0.31-0.93, P=0.027 for major hemorrhage; and OR 0.10, 95% CI 0.06-0.18, P<0.001 for all-cause death, respectively). Conclusions: NOACs could be beneficial for reducing event rates of all types in Japanese NVAF patients. |
---|---|
Mesh-Begriff(e) | Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Asian Continental Ancestry Group ; Atrial Fibrillation/drug therapy ; Atrial Fibrillation/epidemiology ; Female ; Follow-Up Studies ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies ; Registries ; Thromboembolism/chemically induced ; Thromboembolism/epidemiology ; Vitamin K ; Warfarin/administration & dosage ; Warfarin/adverse effects |
Chemische Substanzen | Anticoagulants ; Platelet Aggregation Inhibitors ; Vitamin K (12001-79-5) ; Warfarin (5Q7ZVV76EI) |
Sprache | Englisch |
Erscheinungsdatum | 2016 |
Erscheinungsland | Japan |
Dokumenttyp | Journal Article ; Multicenter Study ; Observational Study |
ZDB-ID | 2068090-9 |
ISSN | 1347-4820 ; 1346-9843 |
ISSN (online) | 1347-4820 |
ISSN | 1346-9843 |
DOI | 10.1253/circj.CJ-16-0066 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Ui IV Zs.74: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.